A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients. International Journal of Biomedical and Advance Research, [S. l.], v. 8, n. 11, p. 407–415, 2017. DOI: 10.7439/ijbar.v8i11.4474. Disponível em: https://ssjournals.co.in/index.php/ijbar/article/view/4474. Acesso em: 13 mar. 2026.